ResMed RMD Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Residential Care Software | $670.9M+7.1% | $661.18M+7.8% | $650.8M+8.2% | $641.44M+9.8% | $626.37M+12.5% | |
| Sleep and Breathing Health | $4.87B+10.7% | $4.74B+9.8% | $4.61B+9.5% | $4.5B+9.8% | $4.4B+11.0% | |
| Operating Income (Loss) by Business | ||||||
| Residential Care Software | $217.63M+13.2% | $212.56M+19.5% | $211.4M+23.8% | $205M+32.7% | $192.29M+36.6% | |
| Sleep And Breathing Health | $2.2B+16.5% | $2.12B+14.6% | $2.03B+15.1% | $1.96B+16.8% | $1.89B+17.7% | |
| Selling, general, and administrative by Business | ||||||
| Residential Care Software | $149.87M+6.2% | $149.04M+4.7% | $143.22M-1.0% | $143.52M-0.3% | $141.08M+2.1% | |
| Sleep And Breathing Health | $573.77M+24.0% | $545.82M+20.2% | $516.91M+15.4% | $491.59M+8.9% | $462.64M+3.0% | |
| Cost of Sales by Business | ||||||
| Residential Care Software | $201.68M+4.0% | $199.17M+3.1% | $197.48M+3.4% | $194.96M+2.5% | $193.99M+4.1% | |
| Sleep And Breathing Health | $1.88B+2.9% | $1.87B+3.4% | $1.86B+3.9% | $1.85B+4.0% | $1.83B+4.5% | |
| Depreciation and amortization by segment by Business | ||||||
| Residential Care Software | $10.71M+15.7% | $10.21M+9.0% | $9.72M-1.4% | $9.47M-7.6% | $9.26M-8.6% | |
| Sleep And Breathing Health | $128.66M+38.6% | $114.62M+24.8% | $112.56M+27.1% | $110.54M+28.4% | $92.85M+9.3% | |
| R&D by Business | ||||||
| Residential Care Software | $101.73M+4.8% | $100.41M+4.5% | $98.7M+3.0% | $97.96M+2.6% | $97.09M+4.0% | |
| Sleep And Breathing Health | $212.54M+10.8% | $203.37M+6.4% | $199.35M+6.2% | $196.34M+5.3% | $191.82M+4.4% | |
| Goodwill (note 4) by Business | ||||||
| Residential Care Software | $8.63B+3.3% | $8.57B— | $8.47B— | $8.43B— | $8.35B— | |
| Sleep And Breathing Health | $3.55B+17.1% | $3.41B— | $3.27B— | $3.16B— | $3.03B— | |
| Adjustment to fair values of preliminary purchase price allocations by Business | ||||||
| Residential Care Software | $0— | $0— | $0— | $0— | —— | |
| Net revenue by segment by Product | ||||||
| Residential Care Software | $670.9M+7.1% | $661.18M+7.8% | $650.8M+8.2% | $641.44M+9.8% | $626.37M+12.5% | |
| Sleep And Breathing Health | $4.87B+10.7% | $4.74B+9.8% | $4.61B+9.5% | $4.5B+9.8% | $4.4B+11.0% | |
| Cost of sales (exclusive of amortization shown separately below) by Product | ||||||
| Residential Care Software | $201.68M+4.6% | $199.17M+3.5% | $197.48M+4.2% | $194.96M+2.5% | $192.9M+3.0% | |
| Sleep And Breathing Health | $1.89B+2.4% | $1.88B+3.0% | $1.87B+3.1% | $1.86B+3.2% | $1.85B+4.4% | |
| Amortization of Intangible Assets by Product | ||||||
| Residential Care Software | $25.57M-1.3% | $25.4M-3.7% | $25.41M-5.6% | $25.47M-7.2% | $25.89M-3.9% | |
| Sleep And Breathing Health | $7.28M+50.3% | $7.04M+49.3% | $6.86M+42.6% | $6.65M+20.5% | $4.84M-14.0% | |
| Net revenue by segment by Geography | ||||||
| Combined Europe, Asia and other markets | $1.65B+12.6% | $1.59B+9.9% | $1.54B+9.0% | $1.51B+9.3% | $1.46B+7.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ResMed break its business down?
- ResMed (RMD) reports net revenue by business across 2 parts — Residential Care Software and Sleep and Breathing Health. Each is extracted from the segment footnotes and tracked over time.
- Where does ResMed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ResMed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
